Patents by Inventor Stephen A. Jacobs

Stephen A. Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969541
    Abstract: Methods and apparatuses for detecting full waste canister and/or fluid flow path blockage conditions are disclosed. Also disclosed are methods and apparatuses for controlling a pump. In some embodiments, flow of fluid can be restricted in a portion of the fluid flow path. A controller can be configured to compare a difference in pressure values upstream and downstream of a fluid flow restrictor to a pressure difference threshold, and determine based on the comparison whether to activate an alarm indicating the full waste canister condition or the fluid flow path blockage condition. The controller can be additionally or alternatively configured to determine a fluid flow using a flow meter, open a selectable valve in response to a comparison of the fluid flow with a fluid flow threshold, determine fluid flow after opening the valve, and determine based on the fluid flow after opening the valve whether to activate the alarm.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: April 30, 2024
    Assignee: Smith & Nephew PLC
    Inventors: Benjamin Gordon, Jake Turner, Edward Yerbury Hartwell, Stephen Jacob, Nathan Wrench, Edward Vernon-Harcourt, David Harris
  • Patent number: 11952408
    Abstract: Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: April 9, 2024
    Assignees: Juno Therapeutics, Inc., Editas Medicine, Inc.
    Inventors: Cameron Brandt, Brian Belmont, Christopher Borges, Stephen Michael Burleigh, Alexandra Croft, Stephen Jacob Goldfless, David Jeffrey Huss, Yue Jiang, Timothy G. Johnstone, David Koppstein, Hieu Nguyen, Christopher Heath Nye, Haley Peper, Blythe D. Sather, Sonia Timberlake, Dean Y. Toy, Queenie Vong, Gordon Grant Welstead, James Sissons
  • Publication number: 20240108076
    Abstract: Smoking articles, and methods for forming such smoking articles, such as an electronic smoking article, are provided. An exemplary smoking article comprises a control body portion having a control body engagement end, and having a first control component therein. A cartridge body portion includes a cartridge body engagement end configured to removably engage the control body engagement end of the control body portion. The cartridge body portion further includes a consumable arrangement comprising at least an aerosol precursor composition and at least one heating element operably engaged therewith, and a second control component. At least the consumable arrangement is configured to be in communication with the first control component upon engagement between the cartridge body and control body portions.
    Type: Application
    Filed: November 2, 2023
    Publication date: April 4, 2024
    Inventors: Stephen Benson Sears, Timothy Brian Nestor, Charles Jacob Novak, III, Steven Lee Alderman, Michael Ryan Galloway, Quentin Paul Guenther, JR., Frederic Philippe Ampolini, Raymond C. Henry, JR., Allen Michael East
  • Patent number: 11933962
    Abstract: Spatial light modulators (SLMs) and systems using same are described. Generally, the system includes a laser, a fixture holding a workpiece to be processed using the laser, illumination optics to illuminate the SLM with laser light, imaging optics to focus modulated light from the SLM onto the workpiece, and a controller to control the laser, the SLM, imaging optics and the fixture to scan the modulated light across a workpiece surface. The SLM includes an array of microelectromechanical system based diffractors, each including an electrostatically deflectable member coupled to a first light reflective surface and to bring light reflected from the first light reflective surface into interference with light reflected from a second light reflective surface in the SLM. The controller is operable to provide analog gray-scale control of an intensity of modulated light reflected from each diffractor by controlling an electrostatic force generated by a driver coupled thereto.
    Type: Grant
    Filed: February 3, 2022
    Date of Patent: March 19, 2024
    Inventors: Stephen Hamann, Alexander Payne, Lars Eng, James Hunter, Tianbo Liu, Gregory Jacob
  • Publication number: 20240090086
    Abstract: The present disclosure relates to a cartridge for an aerosol delivery device such as a smoking article. The cartridge may include a base, a reservoir substrate, and an atomizer. The reservoir substrate may define a cavity therethrough. The atomizer may comprise a liquid transport element and a heating element extending at least partially about the liquid transport element. The atomizer may extend through the cavity through the reservoir substrate such that the heating element is positioned proximate an end of the reservoir substrate. Ends of the liquid transport element may extend to an opposing end of the reservoir substrate. A related method for assembling a cartridge for a smoking article is also provided.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Inventors: John DePiano, David Smith, Charles Jacob Novak, III, Frank S. Silveira, Steven Lee Alderman, Grady Lance Dooly, Frederic Philippe Ampolini, Timothy Brian Nestor, Quentin Paul Guenther, JR., Stephen Benson Sears, John William Wolber, Michael Laine
  • Publication number: 20240076732
    Abstract: Provided herein are methods and composition for immune repertoire sequencing and single cell barcoding. The methods and compositions can be used to pair any two sequences originating from a single cell, such as heavy and light chain antibody sequences, alpha and beta chain T-cell receptor sequences, or gamma and delta chain T-cell receptor sequences, for antibody and T-cell receptor discovery, disease and immune diagnostics, and low error sequencing.
    Type: Application
    Filed: November 10, 2022
    Publication date: March 7, 2024
    Inventors: Francois Vigneault, Adrian Wrangham Briggs, Christopher Ryan Clouser, Stephen Jacob Goldfless, Sonia Timberlake
  • Publication number: 20240066002
    Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
    Type: Application
    Filed: September 22, 2023
    Publication date: February 29, 2024
    Inventors: Vincent Jacob Kalish, Frederick Arthur Brookfield, Stephen Martin Courtney, Lisa Marie Frost, John P. Toscano
  • Publication number: 20230256018
    Abstract: Provided herein are binding molecules, such as those that recognize or bind a peptide epitope of a cancer antigen, such as expressed on a cancer cell, including cells infected with human papilloma virus (HPV) or that contain HPV DNA sequences and/or those that recognize or bind a peptide epitope of HPV 16 E6 or E7, in the context of a major histocompatibility complex (MHC) molecule. Among the provided binding molecules are T cell receptors (TCRs) or antibodies, including antigen-binding fragments thereof, that bind or recognize such peptide epitopes. The present disclosure further relates to engineered cells comprising such binding molecules, e.g., TCRs or antibodies (and chimeric antigen receptors containing the antibodies), and uses thereof in adoptive cell therapy.
    Type: Application
    Filed: June 30, 2022
    Publication date: August 17, 2023
    Applicant: Juno Therapeutics, Inc.
    Inventors: Stephen Jacob GOLDFLESS, Brian BELMONT, Cameron BRANDT, Alexandra CROFT, David Jeffrey HUSS
  • Publication number: 20230071885
    Abstract: According to some implementations of the present disclosure, a system for identifying individuals at risk for PDAC includes a CT scanner, a memory, and a control system. The CT scanner is configured to generate CT image data associated with a pancreas of a patient. The memory stores machine-readable instructions. The control system includes one or more processors configured to execute the machine-readable instructions. The CT image data associated with the pancreas of the patient is received. The received CT image data is processed to output a set of CT image features. The set of CT image features is received as an input to a machine learning PDAC prediction algorithm. An indication of whether the patient is at high risk for PDAC is determined as an output of the machine learning PDAC prediction algorithm.
    Type: Application
    Filed: January 12, 2021
    Publication date: March 9, 2023
    Applicants: CEDARS-SINAI MEDICAL CENTER, SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
    Inventors: Bechien Wu, Srinivas Gaddam, Debiao Li, Stephen Jacob Pandol, Touseef Ahmad Qureshi
  • Patent number: 11471489
    Abstract: Provided herein are binding molecules, such as those that recognize or bind a peptide epitope of a cancer antigen, such as expressed on a cancer cell, including cells infected with human papilloma virus (HPV) or that contain HPV DNA sequences and/or those that recognize or bind a peptide epitope of HPV 16 E6 or E7, in the context of a major histocompatibility complex (MHC) molecule. Among the provided binding molecules are T cell receptors (TCRs) or antibodies, including antigen-binding fragments thereof, that bind or recognize such peptide epitopes. The present disclosure further relates to engineered cells comprising such binding molecules, e.g., TCRs or antibodies (and chimeric antigen receptors containing the antibodies), and uses thereof in adoptive cell therapy.
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: October 18, 2022
    Assignee: Juno Therapeutics, Inc.
    Inventors: Stephen Jacob Goldfless, Brian Belmont, Cameron Brandt, Alexandra Croft, David Jeffrey Huss
  • Patent number: 11430048
    Abstract: Receiving and processing user orders may include receiving an order for an order quantity of a product from a user computing device, retrieving a threshold inventory quantity of the product, retrieving a last known inventory quantity of the product, comparing the threshold inventory quantity with the difference between the last known inventory quantity and the order quantity, performing an asynchronous reservation of the quantity of the product when the threshold inventory quantity is less than the difference between the last known inventory quantity and the order quantity, and performing a synchronous reservation of the quantity of the product when the threshold inventory quantity is greater than the difference between the last known inventory quantity and the order quantity.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: August 30, 2022
    Assignee: Home Depot Product Authority, LLC
    Inventors: Hari Ramamurthy, Angie Brown, Thomas Gamble, Stephen Jacobs, Todd Stormes
  • Publication number: 20220202216
    Abstract: In an example embodiment, there is disclosed herein a sleeve that has a peel-off appliqué or label that includes desired graphics that can be combined with a drink cup or container. The label or appliqué or “collectable” acts as a “mini-poster” that is removable and repositionable. The label may have graphics of sports starts or other things such as musical performers, super heroes, etc. Particular embodiments include interior die cut images within the main graphic as “collectibles within a collectible.
    Type: Application
    Filed: September 20, 2021
    Publication date: June 30, 2022
    Inventor: Stephen Jacobs
  • Publication number: 20220096651
    Abstract: Provided are receptor tyrosine kinase-like orphan receptor 1 (ROR1)-binding molecules, in particular, to human antibodies specific for ROR1, including antibody fragments. The present disclosure further relates to recombinant receptors, including chimeric antigen receptors (CARs) that contain such antibodies or fragments, and polynucleotides that encode the antibodies, antigen-binding fragments or receptors specific for ROR1. The disclosure further relates to genetically engineered cells, containing such ROR1-binding proteins and receptors, and related methods and uses thereof in adoptive cell therapy.
    Type: Application
    Filed: January 28, 2020
    Publication date: March 31, 2022
    Applicant: Juno Therapeutics, Inc.
    Inventors: Andreia COSTA, Rupesh AMIN, Jenna BAILEY, Samriti BEDI, Brian BELMONT, Aye CHEN, Stephen Jacob GOLDFLESS, Eric JEFFERY, Yue JIANG, Yeonjoo OH, Madeline WILLIAMS, Collin HAUSKINS, Catherine SIERRA
  • Publication number: 20220020080
    Abstract: A method for processing user orders for products may include receiving an order for an order quantity of the product from a user computing device, determining that the order management system cannot communicate with the inventory management system to reserve the order quantity of the product, retrieving a last known inventory quantity of the product, retrieving an offline demand quantity for the product, transmitting a confirmation of the order to the user computing device when the sum of the order quantity and the offline demand quantity of the product is less than or equal to the last known inventory quantity of the product, and transmitting a denial of the order to the user computing device when the sum of the order quantity and the offline demand quantity of the product is greater than the last known inventory quantity of the product.
    Type: Application
    Filed: July 28, 2021
    Publication date: January 20, 2022
    Inventors: Hari Ramamurthy, Angie Brown, Thomas Gamble, Stephen Jacobs, David Rogers
  • Patent number: 11122919
    Abstract: In an example embodiment, there is disclosed herein a sleeve that has a peel-off appliqué or label that includes desired graphics that can be combined with a drink cup or container. The label or appliqué or “collectable” acts as a “mini-poster” that is removable and repositionable. The label may have graphics of sports starts or other things such as musical performers, super heroes, etc. Particular embodiments include interior die cut images within the main graphic as “collectibles within a collectible.” In another example embodiment, a container appliqué is applied to the container.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: September 21, 2021
    Assignee: Amscan Inc.
    Inventor: Stephen Jacobs
  • Publication number: 20210284709
    Abstract: Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.
    Type: Application
    Filed: September 28, 2018
    Publication date: September 16, 2021
    Applicants: Juno Therapeutics, Inc., Editas Medicine, Inc.
    Inventors: Cameron BRANDT, Brian BELMONT, Christopher BORGES, Stephen Michael BURLEIGH, Alexandra CROFT, Stephen Jacob GOLDFLESS, David Jeffrey HUSS, Yue JIANG, Timothy G. JOHNSTONE, David KOPPSTEIN, Hieu NGUYEN, Christopher Heath NYE, Haley PEPER, Blythe D. SATHER, Sonia TIMBERLAKE, Dean Y. TOY, Queenie VONG, Gordon Grant WELSTEAD, James SISSONS
  • Patent number: 10982258
    Abstract: Provided herein are methods and composition for immune repertoire sequencing and single cell barcoding. The methods and compositions can be used to pair any two sequences originating from a single cell, such as heavy and light chain antibody sequences, for antibody discovery, disease and immune diagnostics, and low error sequencing.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: April 20, 2021
    Assignee: AbVitro LLC
    Inventors: Francois Vigneault, Adrian Wrangham Briggs, Christopher Ryan Clouser, Stephen Jacob Goldfless, Sonia Timberlake
  • Publication number: 20210079454
    Abstract: Provided herein are methods and composition for immune repertoire sequencing and single cell barcoding. The methods and compositions can be used to pair any two sequences originating from a single cell, such as heavy and light chain antibody sequences, for antibody discovery, disease and immune diagnostics, and low error sequencing.
    Type: Application
    Filed: August 31, 2020
    Publication date: March 18, 2021
    Inventors: Francois Vigneault, Adrian Wrangham Briggs, Christopher Ryan Clouser, Stephen Jacob Goldfless, Sonia Timberlake
  • Patent number: D967753
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: October 25, 2022
    Assignee: Apple Inc.
    Inventors: Joss Giddings, Christopher R. Pasma, David M. Rockford, Mikael Silvanto, Stephen Jacobs Wisler
  • Patent number: D1019809
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: March 26, 2024
    Assignee: Lovevery, Inc.
    Inventors: Stephen Blaise Lawless, Philip Jacob Fouts